• 제목/요약/키워드: HER2

검색결과 2,751건 처리시간 0.034초

Efficacy and Safety of Trastuzumab Added to Standard Treatments for HER2-positive Metastatic Breast Cancer Patients

  • Zhu, Zhen-Li;Zhang, Jun;Chen, Mei-Lan;Li, Ke
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권12호
    • /
    • pp.7111-7116
    • /
    • 2013
  • Introduction: Trastuzumab, an HER2-targeting agents, has shown efficacy in metastatic HER2-positive breast cancer patients. Single-agent clinical trials have evaluated therapeutic regimens using trastuzumab for metastatic breast cancer patients. The aim of our study is to evaluate the efficacy and safety of trastuzumab in combination with chemotherapy or hormone therapy in HER2-positive metastatic breast cancer patients. Methods: A literature research was conducted in PubMed and to identify appropriate studies from relevant reviews. Randomized controlled trials comparing chemotherapy or hormone therapy regimens in combination with trastuzumab were eligible. Dadta on clinical outcomes, including safety, efficacy, and patient characteristics were collected. Results: Seven articles describing five trials were included in our systematic review and meta-analysis. Partners of trastuzumab included in trials were anthracycline, paclitaxel, docetaxel, anastrozole and letrozole. The addition of trastuzumab to chemotherapy improved the overall survival (HR=0.79, 95%CI 0.65-0.96), while to hormone therapy did not (HR=0.85 95%CI 0.56-1.30). All trastuzumab-containing regimens increased cardiac toxicity (RR=3.37, 95%CI 1.26-9.02) and grade III-IV adverse events. Conclusions: Our study supports the addition of trastuzumab to chemotherapy which is effective and tolerated for metastatic breast cancer with HER2+ patients. Of note, more adverse events will occur followed the use of trastuzumab, especially cardiac toxicity, with two treatment regimens.

Pre-treatment Elevated Platelet Count Associates with HER2 Overexpression and Prognosis in Patients with Breast Cancer

  • Gu, Mei-Ling;Yuan, Cai-Jun;Liu, Xiao-Mei;Zhou, Yi-Chao;Di, Shu-Huan;Sun, Fei-Fei;Qu, Quan-Ying
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권13호
    • /
    • pp.5537-5540
    • /
    • 2015
  • Purpose: To research the association between pre-treatment elevated platelet count and clinicopathologic characteristics in breast cancer (BC), as well as explore the relationship between pre-treatment elevated platelet count and HER2 status and prognosis of BC patients. Materials and Methods: A retrospective cohort of BC patients who were newly diagnosed or treated by surgery only and had pathological detection results and platelet values in the Department of Oncology, the First Affiliated Hospital of Liaoning Medical College were enrolled from 1/1/2008 until 31/12/2009, and followed up until 31/12/2014. Age, thrombocyte parameters before chemotherapy and/or radiotherapy, immunohistochemical (IHM) indexes, and regional lymph node (LN) involvement and progression-free survival (PFS) were recorded. Results: A total of 447 eligible subjects were included in this research. As we analyzed, for HER2, positive and negative, the incidence rates of elevated platelet count were 25.8% and 14.7% (P<0.05). In the Cox proportional hazards model both variables were independent risk factors for BC (for HER2, OR, 0.592, 95% confidence interval, CI, 0.355 to 0.985, P=0.044;f or PLT, OR, 0.998, 95% CI, 0.996 to 1.000, P=0.042). For ER, PR, Ki67 and LN involvement, the differences were not statistically significant (P>0.05). Conclusions: In this research, pre-treatment elevated level of platelet count demostrated a significantrelationship with HER2 amplification/overexpression, and both variables significantly influenced the prognosis of BC. However, elevated platelet count did not exhibit any association with ER, PR, Ki67 and LN involvement.

조영제 투여 후 초발한 저린감에 대한 사물탕가미(四物湯加味) 치료 증례보고 (A Case Report of Treatment of Numbness Associated with Contrast Medium Injection using Modified Samul-tang)

  • 권정연;배지용;공경환;고호연
    • 대한한방내과학회지
    • /
    • 제40권5호
    • /
    • pp.983-989
    • /
    • 2019
  • Objective: Many types of delayed adverse reactions, such as long-term numbness, occur after injecting contrast medium, but few clinical studies have reported effective treatments for these reactions. We report that herbal medicine can have a positive clinical effect in patients who have experienced long-term numbness after contrast medium injection. Method: A patient who had felt numbness in her head and whole limbs presented at Semyung University Korean Medicine hospital. Her numbness had first started 2 days after injection of contrast medium, and she had felt it constantly for almost 2 years. After admission at the hospital, she took "modified Samul-tang" herbal medicine (120 cc three times per day) from 29 January 2019 to 2 February 2019. We measured her numbness using a numeric rating scale (NRS) on 29 January and 2 February and we compared both scores to determine the degree of favorable and clinical effects of herbal medicine. Result: The NRS score for numbness was 5 for her head and limbs on the first day (29 January), but after 4 days (2 February), the NRS score decreased to 0 for her head and both arms and hands, and it decreased from 5 to 2 for both her legs and feet. Conclusion: Korean herbal medicine can have positive clinical effects on treating adverse reactions due to injection of contrast medium.

초혼계모의 재혼가족생활 스트레스와 적응에 대한 경험적 연구 (The Experience of the first-married stepmother's stress and adaptation to her stepfamily)

  • 임춘희
    • 대한가정학회지
    • /
    • 제35권5호
    • /
    • pp.73-102
    • /
    • 1997
  • The purpose of this study was to identify the specific and empirical contents in terms of first-married stepmother about her stress and efforts to adapt to her stepfamily. This studies relied on the qualitative research method in order to approach stepmother's subjective experience. There were 6 stepmother respondents who were 6 first-marrieds living in Seoul or Kyoungki area. The data was collected by in-depth personal interview.‘Open coding process’, a part of grounded theory procedures were used to analyzed the data. The major findings can be summarized as follows: 1. When focused o stressors, the stress of stepmothers were categorized into 4 categories. Those were the following: 1 When focused on stressors, the stress of stepmothers were categorized into 4 categories. Those were the following: (1) Stepmother's own problem such as stepmother' identity problem; (2) Problems within stepfamily such as problems about relations with husbands, stepchildren, and her own children; (3) Problems of stepmother family's kin such as relational problems with former spouses, in-laws, and her parent; (4) Problems of social relationship such as isolation and alienation in social relationship and neighbors' prejudice about stepmother. 2. In overcoming stress from stepfamily life and adapting to it, 4 categories were identified as important. Contents of 4 categories were such like this: (1) Stepmother's own efforts - (a) give a positive meaning to marriage or remarriage (b) flexible personality (c) situation-accepting attitude (d) exclusive management of household income (e) job (f) perseverance for time to adaptation; (2) Positive feedback within stepfamily - (a) supportive husband (b) sense of unity as a couple (c) psychological reward from stepchildren (d) existence of stepmother's own child (e) behavior for family solidarity (f) family-centered religious life; (3) Stepfamily's relationship with former spouses such as breakdown in relationship with ex-wives or ex-husbands; (4) Support from stepmothers' kin and people in social network with stepmothers. It was concluded that to reduce stress and to help adapt to stepfamily, stepmother should make an effort, and that her stepfamily and her kin should cooperate and support. In addition, negative stereotype of stepmother and stepfamily should disappeared. It was suggested that studies on stepfamily should be vitalized and that programs for preparing remarriage and counseling for stepfamily should be spread.

  • PDF

탐양호의 조종성능에 관한 연구 (Maneuverabilities of the M.S. TAMYANG)

  • 김정창
    • 수산해양기술연구
    • /
    • 제31권2호
    • /
    • pp.172-177
    • /
    • 1995
  • 부산수산대학교 해양탐사선 탐양호(GT : 653.0tons)의 조종성능을 파악하기 위하여 Z 시험을 행한 결과를 요약하면 다음과 같다. 1. 타각 $10^{\circ}$, 20$^{\circ}$, 30$^{\circ}$의 Z시험에서 방향성 지수 K'는 각각 0.9464, 0.8651, 0.8349이고, 방향성은 타각 $10^{\circ}$일 때가 추종성은 타각 20$^{\circ}$일 때가 좋으며, 대체적으로 대타각을 사용 할 때보다도 소타각을 사용 할 때의 조종성이 더 양호함을 알 수 있다. 2. Over shoot angle은 타각 $10^{\circ}$, 20$^{\circ}$, 30$^{\circ}$일 때 우현전타했을 때는 각각 14.3$^{\circ}$, 32.3$^{\circ}$, 52.1$^{\circ}$이고, 좌현전타했을 때는 14.5$^{\circ}$, 33.5$^{\circ}$, 53.3$^{\circ}$이며, 우현전타 할 때가 좌현전타 할 때보다도 조종성이 더 양호한 경향을 나타냈다. 3. 타각 $10^{\circ}$Z 시험에서 - 조작간 항주거리는 배 길이의 8.8배가되어 조종성표준거리인 5~11배 이내가 되므로 대체적으로 조종성능이 양호하다고 볼 수 있다.

  • PDF

'새바다호의'의 조종성능에 관한 연구 (MANOEUVRABILITIES OF THE M.S. 'SAEBADA')

  • 김기윤
    • 한국수산과학회지
    • /
    • 제12권4호
    • /
    • pp.209-215
    • /
    • 1979
  • 부산수산대학실습선 '새바다'(GT: 2,275.7ton)에 관한 조종성능을 구명하기 위하여, 실선에 의한 Z 조종시험을 한 결과를 요약하면 다음과 같다. 1. '새바다'호의 $10^{\circ}Z$시험에서의 선회성지수 K'값은 1.052, 추종성지수 T' 값은 0.815, $20^{\circ}Z$ 시험에서의 K'값은 0.925, T'값은 0.502, $30^{\circ}Z$ 시험에서의 K' 값은 0.877, T' 값은 0.441로서, 소타각사용시의 조종성능과 대타각사용시의 조종성을 비교하여 보면, 대타각을 사용할 때 보다 추종성을 좋아지나 선회성을 낮아진다는 것을 알 수 있다. 2. '새바다'호의 $10^{\circ}Z$ 시험에서의 선회성지수 K' 값과 추종성지수 T' 값은 어선의 표준식에 가까움으로 어선으로서 양호한 조종성능을 가지고 있다고 볼 수 있었다. 다만 길이와 크기에 비하여 K'값이 약간 적은 수치이며, $10^{\circ}Z,\; 20^{\circ}Z,\;20^{\circ}Z$ 시험에서의 회두각곡선의 overshoot angle이 약간 크므로 추종성은 좋으나 선회성은 낮은 편임을 알 수 있었다. 3. '새바다'호의 조종성능은 추종성에 비하여 선회성이 낮으므로 선회경도 크게 되며, 또한 대각도전타시에 비하여 선회성이 낮아지므로, 충돌이나 좌초를 회피하기 위하여 대각도전타를 할 경우에는 안전한게 접근거리를 크게 두어 한기전타하는 등 조선상주의를 요한다. 4. '새바다'호의 $10^{\circ}$시험에서의 1조작간항주거리하는 배 길이의 약 8.6배로서 일반선박의 조종성표준거리 $5\~11$배의 이내가 되므로 '새바다'호의 조종성능은 총합적으로 양호하다는 것을 알 수 있었다.

  • PDF

HER-2/neu Status: A Neglected Marker of Prognostication and Management of Breast Cancer Patients in India

  • Zubeda, Syeda;Kaipa, Prabhakar Rao;Shaik, Noor Ahmad;Mohiuddin, Mohammed Khaliq;Vaidya, Sireesha;Pavani, Boddana;Srinivasulu, Mukta;Latha, Manolla Madhavi;Hasan, Qurratulain
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권4호
    • /
    • pp.2231-2235
    • /
    • 2013
  • Background: Categorizing breast tumors based on the ER, PR and HER/Neu 2 receptor status is necessary in order to predict outcome and assist in management of breast cancer. Herfe we assessed this question in South Indian patients. Materials and Methods: A total of 619 formalin fixed paraffin embedded breast tumor tissues were collected from pathology archives after receipt of ethical clearance. With the help of primary and secondary conjugated antibodies, expression status of ER, PR and HER2/neu was determined. All the experimental data were assessed for correlations with histopathological features of tumors and clinical presentation of the subjects. Results: In the present study, the ages ranged from 20-87 years with a mean of $50.0{\pm}12.q$ years, and majority of the tumors (84%) were of infiltrating duct cell carcinoma type. Assessment of ER, PR and Her-2/neu expression showed that 46% were triple negative. Interestingly, an inverse relation between ER, PR and HER-2/neu was apparent in 41.2% (p<0.0001) of the tumors, of which 24.5% (p<0.0001) were ER and PR co-negative but HER-2 positive. Conclusions: ER and PR positive tumors are less common (i.e<30%) compared to HER-2/neu positive tumors (i.e>50%) in Indian breast cancer patients, underlining the need for effective diagnostic screening and specific therapeutic managements in order to improve the survival rate of patients in low resource countries such as India.

Hormone Receptor, HER2/NEU and EGFR Expression in Ovarian Carcinoma - is here a Prognostic Phenotype?

  • Demir, Lutfiye;Yigit, Seyran;Sadullahoglu, Canan;Akyol, Murat;Cokmert, Suna;Kucukzeybek, Yuksel;Alacacioglu, Ahmet;Cakalagaoglu, Fulya;Tarhan, Mustafa Oktay
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권22호
    • /
    • pp.9739-9745
    • /
    • 2014
  • Purpose: We aimed to evaluate the effects of hormone receptor, HER2, and epidermal growth factor receptor (EGFR) expression on epithelial ovarian cancer (EOC) prognosis and investigate whether or not phenotypic subtypes might exist. Materials and Methods: The medical records of 82 patients who were diagnosed with EOC between 2003 and 2012 and treated by platinum-based chemotherapy were retrospectively evaluated. Expression of EGFR, oestrogen (ER), progesterone (PR), and cerbB2 (HER2) receptors were assessed immunohistochemically on paraffin-embedded tissues of these patients. Three phenotypic subtypes were defined according to ER, PR, and HER2 expression and associations of these with EGFR expression, clinicopathologic features, platinum sensitivity, and survival were investigated. Results: When we classified EOC patients into three subtypes, 63.4% had hormone receptor positive (HR(+)) (considering breast cancer subtypes, luminal A), 18.3% had triple negative, and 18.3% had HER2(+) disease. EGFR positivity was observed in 37 patients (45.1%) and was significantly more frequent with advanced disease (p=0.013). However, no significant association with other clinicopathologic features and platinum sensitivity was observed. HER2(+) patients had significantly poorer outcomes than HER2(-) counterparts (triple negative and HR positive patients) (p=0.019). Multivariate analysis demonstrated that the strongest risk factor for death was residual disease after primary surgery. Conclusions: Triple negative EOC may not be an aggressive phenotype as in breast cancer. The HER2 positive EOC has more aggressive behaviour compared to triple negative and HR(+) phenotypes. EGFR expression is more frequent in advanced tumours, but is not related with poorer outcome. Additional ovarian cancer molecular subtyping using gene expression analysis may provide more reliable data.

트라스투주맙 치료에 반응을 보인 HER2/neu 양성 전이성 타액관 암종 1예 (Trastuzumab in a Patient with Metastatic Salivary Duct Carcinoma : A Case Report)

  • 공봉한;이지은;최상수;박진희;김연실;김민식;이연수;이지연;홍숙희;강진형
    • 대한두경부종양학회지
    • /
    • 제30권2호
    • /
    • pp.90-94
    • /
    • 2014
  • Salivary duct carcinoma(SDC) is rare malignancy, accounting for approximately 1-3% of all malignant salivary gland tumors. Systemic chemotherapy has been used for stage IV SDC, but there is no consensus on the standard treatment. SDC is histologically similar to ductal carcinoma of breast and often overexpress HER2/neu, hence HER2/neu targeted therapy could be one of treatment options. A 75-year-old Arabian man was diagnosed as SDC of right parotid gland with extensive metastases. He received oral 5-FU as palliative chemotherapy, but he was intolerable to oral chemotherapy due to severe oral mucositis. Considering immunohistochemical stain of tumor tissue showing strong positive for HER2/neu, we decided to administer an anti-HER2/neu antibody, trastuzumab. Follow-up CT scans before the third dose of trastuzumab demonstrated remarkable regression of multiple metastases as well as primary tumor. This case suggests that HER2/neu targeted therapy may be a potential therapeutic option for the SDC patient with overexpression of HER2/neu.

안구편위와 진탕을 동반한 현훈 환자 1례 (A Case of Vertigo with Heterophoria and Nystagmus)

  • 심성용;김경태;엄유식;남혜정;김경준
    • 한방안이비인후피부과학회지
    • /
    • 제17권2호
    • /
    • pp.106-111
    • /
    • 2004
  • Vertigo is a symptom, not a disease. The tenn vertigo refers to the sensation of spinning or whirling that occurs as a result of a disturbance in balance. It's sometimes referred to as a hallucination of motion. The cause of vertigo is very various and generally divided into peripheral and central. A patient presented with severe vertigo, nystagmus and heteophoria. She has taken the BanHaBaekChulChunMa-tang and treated by acupuncture. After 2 days, her symptoms become disappeared and about 1 week, all symptoms except heterophoria were disapperaed. And after 2 weeks, heterophoria was disappeared. In conclusion, we diagnosed her case as vestbular neuronitis by her clinical course, but we also considered her illness as vertebrobasilar insufficiency, TIA etc.

  • PDF